Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANIP compared with KNSA: revenue, margins and what each company keeps, and the suppliers and customers both name
ANIP
ANI Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
KNSA
Kiniksa Pharmaceuticals International, plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANIP
ANI Pharmaceuticals Inc
vs
KNSA
Kiniksa Pharmaceuticals International, plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
ANIP
ANI Pharmaceuticals Inc
Change
69.67
▼
−2.77%
· post 69.67
Mkt cap
$1.6B
Revenue
$291M
Q3 FY26
Revenue
$883M
FY25
KNSA
Kiniksa Pharmaceuticals International, plc
Change
88.11
▼
−8.34%
· post 88.16
Closed
Nov 5 '26
Mkt cap
$6.9B
Revenue
$286M
Q3 FY26
Revenue
$678M
FY25
vs
Compare
Closed
Nov 5 '26
ANIP
ANI Pharmaceuticals Inc
vs
KNSA
Kiniksa Pharmaceuticals International, plc
69.67
▼
−2.77%
post 69.67
Price
88.11
▼
−8.34%
post 88.16
$1.6B
Mkt cap
$6.9B
Q3 FY26
$291M
Revenue
$286M
Q3 FY26
FY25
$883M
Revenue
$678M
FY25
Change
Change
ANIP
69.67
▼
−2.77%
vs
KNSA
88.11
▼
−8.34%
Closed
Nov 5 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ANIP, solid
KNSA, dashed